Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf
Authors:
Open Access
- 5 October 2006
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 14 (4) , 357-365
Abstract
Microphthalmia-associated transcription factor (Mitf) is critically involved in melanin synthesis as well as differentiation of cells of the melanocytic lineage. Some earlier studies suggested that Mitf is also essential in the survival of melanoma cells, but this notion remains controversial. We synthesized short interfering RNA (siRNA) duplexes corresponding to the mitf sequence and transfected them into B16 melanoma. Lipid-mediated transfection in vitro of Mitf-specific siRNA resulted in specific downregulation of Mitf and of the tyrosinase that is a transcriptional target of Mitf. This treatment also remarkably reduced the viability of melanoma cells by inducing apoptosis. To examine the potential feasibility of RNAi therapy against melanoma, B16 cells were subcutaneously injected into syngenic mice and siRNA was transfected into the pre-established tumor by means of electroporation. The Mitf-specific siRNA drastically reduced outgrowth of subcutaneous melanoma, while nonspecific siRNA failed to affect tumor progression. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling-based analysis of tumor specimens demonstrated that the tumor cells transfected with Mitf-siRNA effectively underwent apoptosis in vivo. The present results indicate that Mitf plays important roles in melanoma survival. Intratumor electrotransfer of Mitf-specific siRNA may provide a powerful strategy for therapeutic intervention of malignant melanoma.Keywords
This publication has 67 references indexed in Scilit:
- Vaccination of Japanese patients with advanced melanoma with peptide, tumor lysate or both peptide and tumor lysate‐pulsed mature, monocyte‐derived dendritic cellsThe Journal of Dermatology, 2006
- Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanomaHuman Immunology, 2004
- MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and MelanomaThe American Journal of Pathology, 2003
- Melacine®: an allogeneic melanoma tumor cell lysate vaccineExpert Review of Vaccines, 2003
- Microphthalmia‐Associated Transcription Factor in the Wnt Signaling PathwayPigment Cell Research, 2003
- Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?JNCI: Journal of the National Cancer Institute, 2002
- Functional Analysis of Microphthalmia-associated Transcription Factor in Pigment Cell-specific Transcription of the Human Tyrosinase Family GenesJournal of Biological Chemistry, 1997
- Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene.Molecular and Cellular Biology, 1994
- Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14. 1-p12.3Human Molecular Genetics, 1994
- Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper proteinCell, 1993